Inscription Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Sell
6,208
-476
-7% -$98.9K 0.13% 136
2026
Q1
$1.41M Buy
6,684
+1,416
+27% +$305K 0.15% 120
2025
Q4
$1.08M Buy
5,268
+301
+6% +$56.6K 0.11% 176
2025
Q3
$780K Buy
4,967
+497
+11% +$76.8K 0.08% 242
2025
Q2
$751K Sell
4,470
-1,676
-27% -$249K 0.11% 138
2025
Q1
$688K Buy
+6,146
New +$783K 0.11% 139
2024
Q3
$804K Buy
7,271
+367
+5% +$38.4K 0.12% 131
2024
Q2
$679K Buy
6,904
+758
+12% +$77.2K 0.11% 138
2024
Q1
$688K Buy
+6,146
New +$663K 0.11% 139
2019
Q2
Sell
-3,735
Closed -$182K 122
2019
Q1
$182K Hold
3,735
0.1% 125
2018
Q4
$168K Buy
+3,735
New +$195K 0.09% 138

Other funds holding CAH

Inscription Capital's CAH Position: Q2 2026 in Review

Inscription Capital reduced its Cardinal Health (CAH) stake by 7.1% in Q2 2026, selling an estimated $98.9K and leaving 6,208 shares worth $1.47M. The position accounts for 0.13% of the portfolio, ranked #136.

Inscription Capital first reported a position in CAH in Q4 2018 and has held it in 11 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Inscription Capital held 6,208 shares of Cardinal Health worth $1.47M as of Q2 2026.
  • Inscription Capital sold 476 Cardinal Health shares in Q2 2026, an estimated $98.9K.
  • Cardinal Health made up 0.13% of Inscription Capital's portfolio in Q2 2026, its #136 holding.
  • Inscription Capital first reported a position in Cardinal Health in Q4 2018 and has held it in 11 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.